Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $41.8000 (-4.57%) ($40.0000 - $43.3000) on Fri. Jun. 24, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.72% (three month average) | RSI | 67 | Latest Price | $41.8000(-4.57%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -1.3% a day on average for past five trading days. | Weekly Trend | CAPR advances 11.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(8%) SKYY(8%) ARKK(7%) EWG(7%) EWI(7%) | Factors Impacting CAPR price | CAPR will decline at least -2.86% in a week (0% probabilities). VIXM(-5%) TLT(-5%) GLD(-5%) SLV(-4%) GDX(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.86% (StdDev 5.72%) | Hourly BBV | 0 () | Intraday Trend | 2.7% | | | |
|
5 Day Moving Average | $43.16(-3.15%) | 10 Day Moving Average | $42.02(-0.52%) | 20 Day Moving Average | $37.73(10.79%) | To recent high | -12% | To recent low | 65.2% | Market Cap | $823m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |